| Lentz a prescrit de l'héparine à plusieurs patients. Il a témoigné que l'héparine était "très thérapeutique pour le biofilm" et qu'elle "enrobe la babesia de sorte que lorsque le protozoaire de la babesia pénètre dans les globules rouges", elle "protège les globules rouges contre l'entrée réelle de la babesis", un peu de [[pseudo-science]] que l'on imagine qu'il a appris dans les cours qu'il a suivis. | | Lentz a prescrit de l'héparine à plusieurs patients. Il a témoigné que l'héparine était "très thérapeutique pour le biofilm" et qu'elle "enrobe la babesia de sorte que lorsque le protozoaire de la babesia pénètre dans les globules rouges", elle "protège les globules rouges contre l'entrée réelle de la babesis", un peu de [[pseudo-science]] que l'on imagine qu'il a appris dans les cours qu'il a suivis. |
| + | Sur certains patients, il n'a pas fait d'historique ni de tests physiques, mais il a demandé des tests non standard pour la [[maladie de Lyme]] à partir de courriels qui lui avaient été envoyés par des personnes qu'il n'avait jamais vues en personne. En lisant entre les lignes, il semble que certains de ses correspondants recherchaient activement des “Lyme literate” doctors sur la base d'informations sur Internet ou de recommandations d'amis. Avec d'autres, ses antécédents et ses examens médicaux étaient inadéquats. Par exemple, il ne s'est pas renseigné sur les antécédents de voyage, pour voir si les patients s'étaient rendus dans des régions infestées de Lyme. Comme la ALJ l'a dit, Lentz |
| <ref>https://www.casewatch.net/board/med/lentz/complaint_3.shtml Florida Revokes Medical License of John L. Lentz, M.D. Stephen Barrett, M.D.<br><br>The Florida Medical Board has revoked the medical license of John Luther Lenz, M.D. after concluding that he had improperly diagnosed and unjustifiably treated seven patients with Lyme disease, Bartonellosis (a bacterial infection), and/or Babesiosis (a parasitic infection) and failed to keep adequate records. The charges were made in three administrative complaints. The first and second complaints each involved one patient, and the third complaint (shown below) involved five patients. In July 2016, following hearings, an administrative law judge concluded that Lentz was guilty of "repeated malpractice" and recommended that the Board revoke Lentz's license and impose a $30,000 fine plus costs. In November 2016, the Board accepted this recommendation.<br><br>Lentz practiced in Destin, Florida. In 2009, when he was medical director for Aluwe LLC, the FDA ordered the company to stop representing that its flagship product, Germ Slayer, was effective against Lyme disease, Borellia, malaria, and many other diseases. During Lentz's association with Aluwe, the company's Web site represented him as one of the world's leading authorities on Lyme disease. The company is no longer active.<br><br>Attorney Jann Bellamy has posted a brilliant discussion of the problem of so-called "Lyme literate" doctors who improperly diagnose patients with "chronic Lyme disease" and administer prolonged antibiotic treatment.</ref><br> | | <ref>https://www.casewatch.net/board/med/lentz/complaint_3.shtml Florida Revokes Medical License of John L. Lentz, M.D. Stephen Barrett, M.D.<br><br>The Florida Medical Board has revoked the medical license of John Luther Lenz, M.D. after concluding that he had improperly diagnosed and unjustifiably treated seven patients with Lyme disease, Bartonellosis (a bacterial infection), and/or Babesiosis (a parasitic infection) and failed to keep adequate records. The charges were made in three administrative complaints. The first and second complaints each involved one patient, and the third complaint (shown below) involved five patients. In July 2016, following hearings, an administrative law judge concluded that Lentz was guilty of "repeated malpractice" and recommended that the Board revoke Lentz's license and impose a $30,000 fine plus costs. In November 2016, the Board accepted this recommendation.<br><br>Lentz practiced in Destin, Florida. In 2009, when he was medical director for Aluwe LLC, the FDA ordered the company to stop representing that its flagship product, Germ Slayer, was effective against Lyme disease, Borellia, malaria, and many other diseases. During Lentz's association with Aluwe, the company's Web site represented him as one of the world's leading authorities on Lyme disease. The company is no longer active.<br><br>Attorney Jann Bellamy has posted a brilliant discussion of the problem of so-called "Lyme literate" doctors who improperly diagnose patients with "chronic Lyme disease" and administer prolonged antibiotic treatment.</ref><br> |